Chemed
178 hedge funds and large institutions have $1.59B invested in Chemed in 2013 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 82 increasing their positions, 54 reducing their positions, and 18 closing their positions.
965% more call options, than puts
Call options by funds: $99.2M | Put options by funds: $9.31M
52% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 54
17% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 18
7.84% more ownership
Funds ownership: 111.4% → 119.25% (+7.8%)
4% more capital invested
Capital invested by funds: $1.53B → $1.59B (+$66.5M)
1% more funds holding
Funds holding: 177 → 178 (+1)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
Top Sellers
| 1 |
NAP
New Amsterdam Partners
New York
|
-$16.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$16.2M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$7.38M |
| 4 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
-$6.35M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$5.91M |
CHE Hedge Fund Activity: Q3 2013 in Review
178 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q3 2013, worth a combined $1.59B — up 4.4% from $1.53B a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new CHE positions and 18 closed out — a net gain of 3 holders — while 82 added to existing stakes and 54 trimmed.
The largest buyer was Vulcan Value Partners, adding an estimated $34.5M. The largest seller was New Amsterdam Partners, exiting entirely with an estimated $16.6M sold.
- 178 institutional investors held Chemed (CHE) as of Q3 2013, up from 177 in Q2 2013.
- Funds reported $1.59B of Chemed stock for Q3 2013, up 4.4% quarter-over-quarter.
- 21 funds opened new Chemed positions in Q3 2013 and 18 closed out, a net change of +3 holders.
- The largest Chemed buyer in Q3 2013 was Vulcan Value Partners, an estimated $34.5M added.
- The largest Chemed seller in Q3 2013 was New Amsterdam Partners, an estimated $16.6M sold.
Based on aggregated 13F filings for Q3 2013.